Soren Mogelsvang
Founder at Serpin Pharma, LLC
Profile
Dr. Soren Mogelsvang is Vice President-Research & Development at Serpin Pharma, LLC.
He is on the Board of Directors at Peak Pharmaceuticals, Inc.
He received his undergraduate degree from the University of Copenhagen, a graduate degree from the University of Copenhagen, and a doctorate degree from the University of Cambridge.
Soren Mogelsvang active positions
| Companies | Position | Start |
|---|---|---|
Serpin Pharma, LLC
 Serpin Pharma, LLC Pharmaceuticals: MajorHealth Technology Serpin Pharma, LLC develops therapeutics for autoimmune, inflammatory, and infectious diseases. The private company is based in Manassas, VA. The company was founded by Soren Mogelsvang. | Founder | 2009-12-31 |
Exxel Pharma, Inc.
 Exxel Pharma, Inc. Pharmaceuticals: MajorHealth Technology Exxel Pharma, Inc. is a pharmaceutical company. It is focused on the development of innovative, small molecule based medicines for management of pain and PTSD. The company is headquartered in Vancouver, Canada. | Chief Executive Officer | - |
Former positions of Soren Mogelsvang
| Companies | Position | End |
|---|---|---|
| RETRIEVE MEDICAL HOLDINGS INC | Chief Executive Officer | 2016-01-17 |
Training of Soren Mogelsvang
| University of Cambridge | Doctorate Degree |
| University of Copenhagen | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| RETRIEVE MEDICAL HOLDINGS INC | Health Technology |
| Private companies | 2 |
|---|---|
Serpin Pharma, LLC
Serpin Pharma, LLC Pharmaceuticals: MajorHealth Technology Serpin Pharma, LLC develops therapeutics for autoimmune, inflammatory, and infectious diseases. The private company is based in Manassas, VA. The company was founded by Soren Mogelsvang. | Health Technology |
Exxel Pharma, Inc.
Exxel Pharma, Inc. Pharmaceuticals: MajorHealth Technology Exxel Pharma, Inc. is a pharmaceutical company. It is focused on the development of innovative, small molecule based medicines for management of pain and PTSD. The company is headquartered in Vancouver, Canada. | Health Technology |
- Stock Market
- Insiders
- Soren Mogelsvang
